Table 9Chronic low back pain: physical modalities (low-level laser therapy)

Author, Year, Followup, Pain Duration, Study QualityInterventionPopulationFunction and Pain OutcomesOther Outcomes

Basford, 1999

2 months

Duration of pain: 4.5 vs. 6.5 months

Fair

A. laser (542 /cm2, 90 seconds, two sites, applied to eight points along L2 to S3 paraspinal tissues) (n=27)

12 sessions over 4 weeks

B. Sham laser (n=29)

A vs. B

Age: 48 vs.48 years

Female: 40% vs. 55%

Baseline : 21 vs. 25

Baseline maximal pain, last 24 hours (0-100 ): 35.2 vs. 37.4

A vs. B

2 months

(0-100): 14.7 vs. 22.9, difference −8.2 (95% −13.6 to −2.8); p=0.004

Maximal pain in last 24 hours (0-100 ): 19.1 vs. 35.1, difference −16.0 (95% −28.3 to −3.7); p=0.012

A vs. B

2 months

Patient perception of benefit (, lower = less pain): 28.3 vs. 37.8 (95% −20.9 to 1.9); p=0.101

Djavid, 2007

1.5 months

Duration of pain: 29 months vs. 29 months vs. 25 months

Fair

A. GaAs laser (wavelength 810 nm, 50 wave, and 0.2211 cm2 spot area laser applied to 8 points along L2 to S2-S3 paraspinal tissues, dose 27 ) (n=16)

12 sessions over 6 weeks

B. Low-level laser therapy plus exercise (n=19)

C. Exercise plus sham laser (strengthening, stretching, mobilizing, coordination) (n=18)

A vs. B vs. C

Age: 40 vs. 38 vs. 36 years

Female: 5% vs. 7% vs. 2%

Baseline (0-100): 33.0 vs. 31.8

Baseline pain (0-10 ): 7.3 vs. 6.3

A vs. C

1.5 months

(0-100): 20.8 vs. 24.1, difference in change from baseline −4.4 (95% −11.4 to 2.5)

Pain (0-10 ): 4.4 vs. 4.3, difference in change from baseline −0.9 (95% −2.5 to 0.7)

A vs. B

1.5 months

(0-100): 20.8 vs. 16.8 difference in change from baseline −4.4 (95% −11.4 to 2.5)

Pain (0-10 ): 4.4 vs. 2.4, difference in change from baseline −0.9 (95% −2.5 to 0.7)

Soriano, 1998

6 months

Duration of pain: greater than 3 months

Poor

A GaAs laser (wavelength 904 nm, pulse frequency 10,000 , pulse width 200 nsec, peak power 20W, average power 40mW, administered at dose of 4 per point to pain areas) (n=38)

10 sessions over 5 weeks

B. Sham laser (n=33)

A vs. B

Age: 63 vs. 64 years

Female: 58% vs. 52%

Baseline function:

Baseline pain (1 to 10): 7.9 vs. 8.1

6 months

No pain: 44.7% vs. 15%; p<0.01

Pain recurrence in subgroup of patients with a good or excellent response at end of treatment: 35 % vs. 70%; p=

=confidence interval; = hertz; = Joules per square centimeter; = megawatt; = neodymium-doped yttrium aluminum garnet; = not reported; = Oswestry Disability Index; = visual analog scale

a

Unless otherwise noted, followup time is calculated from the end of the treatment period

From: Results

Cover of Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review Update
Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review Update [Internet].
Comparative Effectiveness Review, No. 227.
Skelly AC, Chou R, Dettori JR, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

External link. Please review our privacy policy.